Fanciulli Alessandra, Leys Fabian, Krbot Skorić Magdalena, Carneiro Diogo Reis, Calandra-Buonaura Giovanna, Camaradou Jennifer, Chiaro Giacomo, Cortelli Pietro, Falup-Pecurariu Cristian, Granata Roberta, Guaraldi Pietro, Helbok Raimund, Hilz Max J, Iodice Valeria, Jordan Jens, Kaal Evert C A, Kamondi Anita, Pavy Le Traon Anne, Rocha Isabel, Sellner Johann, Senard Jean Michel, Terkelsen Astrid, Wenning Gregor K, Moro Elena, Berger Thomas, Thijs Roland D, Struhal Walter, Habek Mario
Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria.
Department of Neurology, University Hospital Centre, Zagreb, Croatia.
Eur J Neurol. 2023 Mar 15. doi: 10.1111/ene.15787.
To investigate the impact of the coronavirus-disease-2019 (COVID-19) pandemic on European clinical autonomic practice.
Eighty-four neurology-driven or interdisciplinary autonomic centers in 22 European countries were invited to fill in a web-based survey between September and November 2021.
Forty-six centers completed the survey (55%). During the first pandemic year, the number of performed tilt-table tests, autonomic outpatient and inpatient visits decreased respectively by 50%, 45% and 53%, and every-third center reported major adverse events due to postponed examinations or visits. The most frequent newly-diagnosed or worsened cardiovascular autonomic disorders after COVID-19 infection included postural orthostatic tachycardia syndrome (POTS), orthostatic hypotension, and recurrent vasovagal syncope, deemed likely related to the infection by ≥50% of the responders. Forty-seven percent of the responders also reported about people with new-onset of orthostatic intolerance, but negative tilt-table findings, and 16% about people with psychogenic pseudosyncope after COVID-19. Most patients were treated non-pharmacologically and symptomatic recovery at follow-up was observed in ≥45% of cases. By contrast, low frequencies of newly-diagnosed cardiovascular autonomic disorders following COVID-19 vaccination were reported, most frequently POTS and recurrent vasovagal syncope, and most of the responders judged a causal association unlikely. Non-pharmacological measures were the preferred treatment choice, with 50-100% recovery rates at follow-up.
Cardiovascular autonomic disorders may develop or worsen following a COVID-19 infection, while the association with COVID-19 vaccines remains controversial. Despite the severe pandemic impact on European clinical autonomic practice, a specialized diagnostic work-up was pivotal to identify non-autonomic disorders in people with post-COVID-19 orthostatic complaints.
探讨2019年冠状病毒病(COVID-19)大流行对欧洲临床自主神经科实践的影响。
邀请欧洲22个国家的84个由神经科主导或跨学科的自主神经中心在2021年9月至11月期间填写一项基于网络的调查问卷。
46个中心完成了调查(55%)。在大流行的第一年,进行的倾斜试验、自主神经科门诊和住院就诊次数分别减少了50%、45%和53%,每三个中心中就有一个报告称因检查或就诊推迟出现了重大不良事件。COVID-19感染后新诊断或病情加重的心血管自主神经障碍最常见的包括体位性直立性心动过速综合征(POTS)、直立性低血压和复发性血管迷走性晕厥,≥50%的受访者认为这些可能与感染有关。47%的受访者还报告了体位不耐受新发但倾斜试验结果为阴性的患者,16%的受访者报告了COVID-19后出现心因性假性晕厥的患者。大多数患者接受了非药物治疗,随访时≥45%的病例症状得到缓解。相比之下,报告的COVID-19疫苗接种后新诊断的心血管自主神经障碍发生率较低,最常见的是POTS和复发性血管迷走性晕厥,大多数受访者认为不太可能存在因果关系。非药物措施是首选的治疗方法,随访时恢复率为50-100%。
COVID-19感染后心血管自主神经障碍可能会发生或加重,而与COVID-19疫苗的关联仍存在争议。尽管大流行对欧洲临床自主神经科实践产生了严重影响,但专门的诊断检查对于识别COVID-19后体位性不适患者的非自主神经障碍至关重要。